PHARMOS CORP·4

Dec 2, 12:56 PM ET

RIESENFELD GAD 4

4 · PHARMOS CORP · Filed Dec 2, 2004

Insider Transaction Report

Form 4
Period: 2004-12-01
RIESENFELD GAD
President and COO
Transactions
  • Exercise/Conversion

    Common Stock

    2004-12-01$2.50/sh+1,701$4,253262,516 total
  • Sale

    Common Stock

    2004-12-01$3.95/sh1,701$6,719260,815 total
  • Exercise/Conversion

    Stock Options

    2004-12-011,7010 total
    Exercise: $2.50From: 1996-10-31Exp: 2005-10-31Common Stock (1,701 underlying)
Footnotes (1)
  • [F1]Sale is pursuant to a 10b5-1 trading plan previously established by Dr. Riesenfeld.

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT